In this study, we combined a CRISPR/Cas9-assisted precision genome editing technology derived from a bacterial adaptive immune system—clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas)9—to generate a PC9 lung cancer cell line harboring EGFR T790M. The gene discussed is EGFR; the disease is lung carcinoma.